# ALISKIREN HEMIFUMARATE
> **ANDA206665** · Abbreviated New Drug Application (Generic) · Sponsor: PH HEALTH · Approved 2019-03-22
## Drug
- **FDA Application Number:** ANDA206665
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ALISKIREN HEMIFUMARATE
- **Generic name:** ALISKIREN
- **Active ingredients:** ALISKIREN HEMIFUMARATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** PH HEALTH
- **Manufacturer:** Endo USA, Inc.
- **First approval:** 2019-03-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206665)
---
*AI Analytics · CC0 1.0*